Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 28, 2011 PRXL, ACV, WDR, BCR, NVLS, EMN Expected To Be Up After Next Earnings Releases
January 28, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Monday, January 31st 2011 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and January earnings reports. PAREXEL INTERNATIONAL CORP (NASDAQ:PRXL), ALBERTO-CULVER CO (NYSE:ACV), WADDELL & REED FINANCIAL-A (NYSE:WDR), CR BARD INC (NYSE:BCR), NOVELLUS SYSTEMS INC (NASDAQ:NVLS), Eastman Chemical Co (NYSE:EMN) are all expected to be Up After their earnings are released Monday. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up After earnings are released Monday:
Symbol Company # of Reports Quarter Release Time
PRXL PAREXEL INTERNATIONAL CORP January Earnings Q2 After
ACV ALBERTO-CULVER CO 12 Quarter Q1 Before
WDR WADDELL & REED FINANCIAL-A 12 Quarter Q4 Before
BCR CR BARD INC 6 Quarter Q4 After
NVLS NOVELLUS SYSTEMS INC 12 Quarter Q4 After
EMN Eastman Chemical Co 6 Quarter Q4 After
This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.
PAREXEL INTERNATIONAL CORP (NASDAQ:PRXL) - PAREXEL International Corporation, a biopharmaceutical services company, provides clinical research, medical communications services, consulting and informatics, and technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. It operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics, Inc. (Perceptive). The CRS segment provides clinical trials management and biostatistics, data management, and clinical pharmacology, as well as related medical advisory, patient recruitment, and investigator site services. It manages various aspects of clinical trials, including study and protocol design, case report form design, site and investigator recruitment, patient enrollment, study monitoring and data collection, data analysis, report writing, and medical services. This segment provides services in various therapeutic areas, including cardiology, oncology, infectious diseases, neurology, allergy/immunology, endocrinology/metabolism, gastroenterology, obstetrics/gynecology, orthopedics, pediatrics, psychiatry, and transplantation. The PCMS segment offers technical advice in areas, such as drug development, regulatory affairs, and biopharmaceutical process and management consulting. It also provides market development, product development, and targeted communications services in support of product launch. In addition, its consultants identify alternatives and propose solutions to address clients product development, registration, and commercialization issues, as well as offers health policy consulting and reimbursement services. The Perceptive segment provides information technology solutions comprising medical imaging services, RTSM/integrated voice response products, CTMS, EDC, Web-based portals, systems integration, and patient diary applications. The company was founded in 1983 and is headquartered in Waltham, Massachusetts.
ALBERTO-CULVER CO (NYSE:ACV) - Alberto-Culver Company and its subsidiaries operates in consumer packaged goods and Cederroth international businesses. The consumer packaged goods business develops, manufactures, distributes, and markets branded beauty care products, as well as branded food and household products in the United States and approximately 100 other countries. The Cederroth International business manufactures, markets, and distributes beauty and health care products in Scandinavia and in other parts of Europe. Its beauty and health care products include various hair care products, skin care products, feminine deodorant sprays, and ethnic hair care products; and food and household products comprise salt-free seasoning blends, anti-static spray, butter flavored sprinkles, sugar substitutes, and furniture polish. The company also offers adhesive bandages, antacids, salt substitute, dietary supplements, cotton buds, wet wipes, liquid soaps, anti-perspirants and cologne for women, shampoo and shower products, artificial sweeteners, skin care products, detergents, natural pharmaceuticals, and herbal multivitamin products, as well as distributes toothbrushes in Scandinavia. In addition, it sells various skin care products in Poland and eastern Europe. The company distributes its beauty and health care products through its direct sales force, as well as through independent brokers and licensees; food and household products through retail outlets such as mass merchandisers, supermarkets, drug stores, beauty salons, barber shops, dollar stores, wholesalers, and various stores; and hair care products primarily through mass merchandisers, drug stores and supermarkets, and beauty supply outlets and beauty distributors. It sells its consumer products through independent distributors and licensees to various retail outlets. Alberto-Culver is based in Melrose Park, Illinois.
WADDELL & REED FINANCIAL-A (NYSE:WDR) - Waddell & Reed Financial, Inc., through its subsidiaries, provides investment management, investment product underwriting and distribution, and shareholder services administration to mutual funds, and institutional and separately managed accounts in the United States. The company operates as an investment adviser for institutional and other private investors, and provides sub advisory services to other investment companies, as well as manages assets for defined benefit pension plans, other investment companies, defined contribution plans, endowments, and high net worth clients. It also offers variable annuity products, retirement and life insurance products, and disability products, as well as asset allocation investment advisory products, including managed allocation portfolio and strategic portfolio allocation. The company distributes investment products through independent financial advisors, broker/dealers, registered investment advisors, and various retirement platforms; and markets investment advisory services to institutional investors directly or through consultants. Waddell & Reed Financial, Inc. was founded in 1937 and is based in Overland Park, Kansas.
CR BARD INC (NYSE:BCR) - C. R. Bard, Inc., together with its subsidiaries, engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. The companys vascular products include percutaneous transluminal angioplasty catheters, guidewires, introducers, and accessories; peripheral vascular stents and stent grafts, vena cava filters, and biopsy devices; electrophysiology products, such as electrophysiology diagnostic, therapeutic, and temporary pacing electrode catheters, as well as laboratory systems; and fabrics, meshes, and implantable vascular grafts. Its urology products comprise infection control Foley catheters to reduce the rate of urinary tract infections; surgical slings used to treat stress urinary incontinence; natural and synthetic devices to treat pelvic floor and vaginal prolapse; brachytherapy services, devices, and radioactive seeds used to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for ureteroscopic procedures and stone removal; fecal incontinence products; and catheter stabilization devices. The company offers various devices to treat and manage cancers, and other diseases and disorders, including specialty access catheters, ports, vascular access ultrasound devices, and enteral feeding devices. Its surgical specialty products include implanted patches and fixation systems for hernia and other soft tissue repairs; irrigation devices for orthopedic, laparoscopic, and gynecological procedures; and products for topical hemostasis. C. R. Bard sells its products directly and through distributors to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company was founded in 1907 and is based in Murray Hill, New Jersey.
NOVELLUS SYSTEMS INC (NASDAQ:NVLS) - Novellus Systems, Inc., together with its subsidiaries, develops, manufactures, sells, and supports equipment used in the fabrication of integrated circuits. It operates in two segments, Semiconductor Group and Industrial Applications Group. The Semiconductor Group segment manufactures and supplies equipment used in the deposition of thin dielectric and metal films, as well as equipment used in complementary manufacturing steps, including surface preparation and ultraviolet thermal processing. Its deposition systems use chemical vapor deposition (CVD), physical vapor deposition (PVD), and electrochemical deposition (ECD) processes to form transistor, capacitor, and interconnect layers in an integrated circuit. This segments High-Density Plasma CVD (HDP-CVD) and Plasma-Enhanced CVD (PECVD) systems employ chemical plasma to deposit dielectric material within the gaps formed by the etching of aluminum, or as a blanket film that can be etched with patterns for depositing conductive materials into the etched dielectric. Its CVD Tungsten systems are used to deposit conductive contacts between transistors and interconnect; PVD systems are used to deposit conductive aluminum and copper metal layers by sputtering metal atoms from the surface of a target source; and Electrofil ECD systems are used to deposit copper to form the conductive wiring on integrated circuits using copper interconnects. The Industrial Applications Group segment offers industrial product range, including single and double-sided grinding, lapping, and polishing machines; double-sided machines, which operate in batch processing mode for flat surfaces; and inner and outer diameter surface grinders for cylindrical surfaces, creep feed grinders, through-feed grinders, and deburring systems. Novellus Systems sells its products primarily in Europe, the United States, Korea, Japan, China, Taiwan, and southeast Asia. The company was founded in 1984 and is headquartered in San Jose, California.
Eastman Chemical Co (NYSE:EMN) - Eastman Chemical Company (Eastman), incorporated in 1993, is a chemical company engaged in the manufacture and sale of a portfolio of chemicals, plastics and fibers. Eastman is a producer of polyethylene terephthalate (PET) polymers for packaging, and a supplier of raw materials for coatings, adhesives, specialty plastic products and other formulated products, and of cellulose acetate fibers. Eastman is aligned into three divisions: Eastman, Voridian and Developing Businesses, with a total of six operating segments. Eastman Division consists of the Coatings, Adhesives, Specialty Polymers and Inks (CASPI) segment, the Performance Chemicals and Intermediates (PCI) segment, and the Specialty Plastics (SP) segment. Voridian Division contains the Polymers segment and the Fibers segment. Developing Businesses Division contains the Developing Businesses (DB) segment.
Eastman Division
Through the CASPI segment, Eastman Division manufactures raw materials, liquid vehicles, additives and specialty polymers, all of which are integral to the production of paints and coatings, inks, adhesives and other formulated products. The CASPI segment focuses on producing raw materials. During the year ended December 31, 2005, the continuing product lines within the CASPI segment had sales revenue of approximately 18% of Eastman's total sales and 36% of Eastman Division's total sales.
On July 31, 2004, the Company completed the sale of certain businesses, product lines and related assets within the CASPI segment. The divested businesses and product lines were acrylate ester monomers, composites (unsaturated polyester resins), inks and graphic arts raw materials, liquid resins, powder resins and textile chemicals.
The Company's PCI segment manufactures products that are used in a variety of markets, and industrial and consumer applications, including chemicals for agricultural intermediates, fibers, food and beverage ingredients, photographic chemicals, pharmaceutical intermediates, polymer compounding and chemical manufacturing intermediates. The PCI segment also offers custom manufacturing services through its custom synthesis business.
The SP segment produces specialized copolyesters and cellulosic plastics that possess performance properties for value-added end uses, such as appliances, store fixtures and displays, building and construction, electronic packaging, medical devices and packaging, personal care and cosmetics, performance films, tape and labels, fibers/non-wovens, photographic and optical film, graphic arts and general packaging.
Eastman competes with Dow Chemical Company (Dow), BASF Corporation (BASF), Exxon Mobil Corporation, Celanese AG, Exxon Mobil Corporation, Bayer AG, GE Plastics, Cyro, Ineos, Atoglas, SK Chemical Industries, Selenis, Industrias de Polimeros, S. A., Polyone, OxyVinyls, Acetati SpA and Daicel Chemical Industries, Ltd.
Voridian Division
The Polymers segment contains two principal product lines, PET polymers and polyethylene (PE). The PET polymers product line is supplied global. The PE product line is primarily supplied in North America.
The Fibers segment is made up of acetate tow, acetate yarn and acetyl chemical products. The Voridian Division has eight manufacturing plants in six countries, as well as access to PET polymers production through two contract manufacturing arrangements in Asia. In 2005, the Polymers segment's revenues represented 36% of the Company's total sales and 74% of Voridian Division's total sales. The segment consists of two product lines, PET polymers and PE.
The Company competes with DAK Americas, Equipolymers, Far Eastern Textiles Ltd, Invista, M&G, Nan Ya Plastics Company and Reliance Industries.
Developing Businesses Division
The DB segment includes new businesses and certain investments in growth opportunities. The DB segment consists of early stage businesses, including Eastman's Gasification Services and Centrus Corporation (Centrus), a food safety diagnostics business, which was sold in February 2006. The business operations of the Co
SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com
www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.
INVESTMENTS & TRADING
SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
About SQUEEZETRIGGER.COM
WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.
SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.
All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.
Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.
By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.
Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.
Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.
Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com
SqueezeTrigger is a registered trademark, Reg. No. 3,120,641
- WOPRAI
- support@woprai.com